医学
缺血
炎症
药理学
神经保护
下调和上调
神经血管束
脑缺血
小胶质细胞
大脑中动脉
脑血流
缺血性中风
麻醉
血脑屏障
创伤性脑损伤
冲程(发动机)
海马体
促炎细胞因子
肿瘤坏死因子α
海马结构
免疫学
心脏病学
内科学
病理
中枢神经系统
生物
机械工程
生物化学
基因
工程类
作者
Chunsheng Yang,Ai Guo,Yulin Li,Kaibin Shi,Fu-Dong Shi,Minshu Li
出处
期刊:Aging and Disease
[Buck Institute for Research on Aging]
日期:2019-10-01
卷期号:10 (5): 964-964
被引量:34
标识
DOI:10.14336/ad.2019.0608
摘要
Dl-3-n-butylphthalide (NBP) is a synthetic compound that has been approved for the treatment of ischemic stroke in China. The mechanisms underlying the treatment efficacy of NBP have been reported in multiple studies and remain controversial. Here, we show that NBP treatment attenuated ischemic brain injury in mice subjected to transient middle cerebral artery occlusion or photothrombosis-induced permanent cerebral ischemia. NBP induced downregulation of intercellular adhesion molecule 1 and protease-activated receptor 1 in cerebrovascular endothelial cells after cerebral ischemia and reperfusion. This effect was associated with the reduced brain infiltration of myeloid cells and improved cerebral blood flow after reperfusion. The beneficial effects of NBP were diminished in mice subjected to the depletion of Gr1+ myeloid cells before brain ischemia. Therefore, the restriction of neurovascular inflammation is a key mode of action for NBP in ischemic stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI